{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:15:35Z","timestamp":1789539335850,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cholestatic liver diseases are a major source of morbidity and mortality that can progress to end-stage liver disease and hyperbilirubinemia is a hallmark of cholestasis. There are few effective medical therapies for primary biliary cholangitis, primary sclerosing cholangitis and other cholestatic liver diseases, in part, due to our incomplete understanding of the pathogenesis of cholestatic liver injury. The hepatic unfolded protein response (UPR) is an adaptive cellular response to endoplasmic reticulum stress that is important in the pathogenesis of many liver diseases and recent animal studies have demonstrated the importance of the UPR in the pathogenesis of cholestatic liver injury. However, the role of the UPR in human cholestatic liver diseases is largely unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>RNA was extracted from liver biopsies from patients after liver transplantation. RNA-seq was performed to determine the transcriptional profile and hepatic UPR gene expression that is associated with liver injury and cholestasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Transcriptome analysis revealed that patients with hyperbilirubinemia had enhanced expression of hepatic UPR pathways. Alternatively, liver biopsy samples from patients with acute rejection had enhanced gene expression of\n                      <jats:italic>LAG3<\/jats:italic>\n                      and\n                      <jats:italic>CDK1<\/jats:italic>\n                      . Pearson correlation analysis of serum alanine aminotransferase, aspartate aminotransferase and total bilirubin levels demonstrated significant correlations with the hepatic expression of several UPR genes, as well as genes involved in hepatic bile acid metabolism and inflammation. In contrast, serum alkaline phosphatase levels were correlated with the level of hepatic bile acid metabolism gene expression but not liver UPR gene expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, these data indicate that hepatic UPR pathways are increased in cholestatic human liver biopsy samples and supports an important role of the UPR in the mechanism of human cholestatic liver injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-022-02459-8","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T05:02:49Z","timestamp":1660107769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Expression of unfolded protein response genes in post-transplantation liver biopsies"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaoying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stela","family":"Celaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Levitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"issue":"Suppl 1","key":"2459_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/liv.13306","volume":"37","author":"E de Vries","year":"2017","unstructured":"de Vries E, Beuers U. Management of cholestatic disease in 2017. Liver Int. 2017;37(Suppl 1):123\u20139.","journal-title":"Liver Int"},{"key":"2459_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fmed.2020.00149","volume":"7","author":"A Kriegermeier","year":"2020","unstructured":"Kriegermeier A, Green R. Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies. Front Med. 2020;7:149.","journal-title":"Front Med"},{"issue":"1","key":"2459_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","volume":"18","author":"B Fosby","year":"2012","unstructured":"Fosby B, Karlsen TH, Melum E. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol. 2012;18(1):1\u201315.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2459_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/apt.15148","volume":"49","author":"IC Steenstraten","year":"2019","unstructured":"Steenstraten IC, Sebib Korkmaz K, Trivedi PJ, Inderson A, van Hoek B, Rodriguez Girondo MDM, et al. Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation. Aliment Pharmacol Ther. 2019;49(6):636\u201343.","journal-title":"Aliment Pharmacol Ther"},{"key":"2459_CR5","doi-asserted-by":"publisher","first-page":"104021","DOI":"10.1016\/j.cellimm.2019.104021","volume":"347","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Kono H, Leung PSC, Gershwin ME. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus. Cell Immunol. 2020;347:104021.","journal-title":"Cell Immunol"},{"issue":"6\u20137","key":"2459_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.clinre.2011.02.007","volume":"35","author":"M Carbone","year":"2011","unstructured":"Carbone M, Neuberger J. Liver transplantation in PBC and PSC: indications and disease recurrence. Clin Res Hepatol Gastroenterol. 2011;35(6\u20137):446\u201354.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"2459_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/hep.31488","volume":"73","author":"Y Gindin","year":"2021","unstructured":"Gindin Y, Chung C, Jiang Z, Zhou JZ, Xu J, Billin AN, et al. A fibrosis-independent hepatic transcriptomic signature identifies drivers of disease progression in primary sclerosing cholangitis. Hepatology. 2021;73(3):1105\u201316.","journal-title":"Hepatology"},{"issue":"1","key":"2459_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/hep.29815","volume":"68","author":"X Liu","year":"2018","unstructured":"Liu X, Guo GL, Kong B, Hilburn DB, Hubchak SC, Park S, et al. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice. Hepatology. 2018;68(1):304\u201316.","journal-title":"Hepatology"},{"issue":"1","key":"2459_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.livres.2019.01.002","volume":"3","author":"X Liu","year":"2019","unstructured":"Liu X, Green RM. Endoplasmic reticulum stress and liver diseases. Liver Res. 2019;3(1):55\u201364.","journal-title":"Liver Res"},{"issue":"4","key":"2459_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","volume":"54","author":"H Malhi","year":"2011","unstructured":"Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol. 2011;54(4):795\u2013809.","journal-title":"J Hepatol"},{"issue":"4","key":"2459_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-0033-1358522","volume":"33","author":"A Henkel","year":"2013","unstructured":"Henkel A, Green RM. The unfolded protein response in fatty liver disease. Semin Liver Dis. 2013;33(4):321\u20139.","journal-title":"Semin Liver Dis"},{"issue":"2","key":"2459_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/febs.14608","volume":"286","author":"A Almanza","year":"2019","unstructured":"Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, et al. Endoplasmic reticulum stress signalling\u2014from basic mechanisms to clinical applications. FEBS J. 2019;286(2):241\u201378.","journal-title":"FEBS J"},{"issue":"7","key":"2459_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrm2199","volume":"8","author":"D Ron","year":"2007","unstructured":"Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8(7):519\u201329.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2459_CR14","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/lt.20779","volume":"12","author":"BS Horoldt","year":"2006","unstructured":"Horoldt BS, Burattin M, Gunson BK, Bramhall SR, Nightingale P, Hubscher SG, et al. Does the Banff rejection activity index predict outcome in patients with early acute cellular rejection following liver transplantation? Liver Transpl. 2006;12(7):1144\u201351.","journal-title":"Liver Transpl"},{"issue":"7","key":"2459_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375(7):631\u201343.","journal-title":"N Engl J Med"},{"issue":"1","key":"2459_CR16","doi-asserted-by":"publisher","first-page":"e0261789","DOI":"10.1371\/journal.pone.0261789","volume":"17","author":"X Liu","year":"2022","unstructured":"Liu X, Taylor SA, Gromer KD, Zhang D, Hubchak SC, LeCuyer BE, et al. Mechanisms of liver injury in high fat sugar diet fed mice that lack hepatocyte X-box binding protein 1. PLoS ONE. 2022;17(1):e0261789.","journal-title":"PLoS ONE"},{"issue":"1","key":"2459_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"12","key":"2459_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"1","key":"2459_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2009","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"10","key":"2459_CR20","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40(10):4288\u201397.","journal-title":"Nucleic Acids Res"},{"key":"2459_CR21","doi-asserted-by":"crossref","unstructured":"Chen Y, Lun ATL, Smyth GK. From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline [version 2; peer review: 5 approved]. F1000 research. 2016;5:1438-.","DOI":"10.12688\/f1000research.8987.1"},{"issue":"3","key":"2459_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267\u201373.","journal-title":"Nat Genet"},{"issue":"43","key":"2459_CR23","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"2459_CR24","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41589-020-0584-z","volume":"16","author":"JMD Grandjean","year":"2020","unstructured":"Grandjean JMD, Madhavan A, Cech L, Seguinot BO, Paxman RJ, Smith E, et al. Pharmacologic IRE1\/XBP1s activation confers targeted ER proteostasis reprogramming. Nat Chem Biol. 2020;16(10):1052\u201361.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"2459_CR25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","volume":"134","author":"P Puri","year":"2008","unstructured":"Puri P, Mirshahi F, Cheung O, Natarajan R, Maher JW, Kellum JM, et al. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology. 2008;134(2):568\u201376.","journal-title":"Gastroenterology"},{"key":"2459_CR26","doi-asserted-by":"publisher","first-page":"39342","DOI":"10.1038\/srep39342","volume":"6","author":"RS Kim","year":"2016","unstructured":"Kim RS, Hasegawa D, Goossens N, Tsuchida T, Athwal V, Sun X, et al. The XBP1 arm of the unfolded protein response induces fibrogenic activity in hepatic stellate cells through autophagy. Sci Rep. 2016;6:39342.","journal-title":"Sci Rep"},{"issue":"6","key":"2459_CR27","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1002\/hep.32031","volume":"74","author":"A Kriegermeier","year":"2021","unstructured":"Kriegermeier A, Hyon A, Sommars M, Hubchak S, LeCuyer B, Liu X, et al. Hepatic X-Box binding protein 1 and unfolded protein response is impaired in weanling mice with resultant hepatic injury. Hepatology. 2021;74(6):3362\u201375.","journal-title":"Hepatology"},{"key":"2459_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/TP.0000000000003895","volume":"106","author":"J Levitsky","year":"2022","unstructured":"Levitsky J, Kandpal M, Guo K, Zhao L, Kurian S, Whisenant T, et al. Prediction of liver transplant rejection with a biologically relevant gene expression signature. Transplantation. 2022;106:1004\u201311.","journal-title":"Transplantation"},{"issue":"1","key":"2459_CR29","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1038\/srep06649","volume":"4","author":"M Morita","year":"2014","unstructured":"Morita M, Chen J, Fujino M, Kitazawa Y, Sugioka A, Zhong L, et al. Identification of microRNAs involved in acute rejection and spontaneous tolerance in murine hepatic allografts. Sci Rep. 2014;4(1):6649.","journal-title":"Sci Rep"},{"issue":"2","key":"2459_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/biomedicines6020041","volume":"6","author":"NP Lee","year":"2018","unstructured":"Lee NP, Wu H, Ng KTP, Luo R, Lam TW, Lo CM, et al. Transcriptome analysis of acute phase liver graft injury in liver transplantation. Biomedicines. 2018;6(2):41.","journal-title":"Biomedicines"},{"issue":"2","key":"2459_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jcmgh.2016.11.006","volume":"3","author":"AS Henkel","year":"2017","unstructured":"Henkel AS, LeCuyer B, Olivares S, Green RM. Endoplasmic reticulum stress regulates hepatic bile acid metabolism in mice. Cell Mol Gastroenterol Hepatol. 2017;3(2):261\u201371.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"2459_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jcmgh.2016.12.007","volume":"3","author":"G Guo","year":"2017","unstructured":"Guo G. Endoplasmic reticulum stress emerges as novel regulator for bile acid synthesis. Cell Mol Gastroenterol Hepatol. 2017;3(2):135.","journal-title":"Cell Mol Gastroenterol Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02459-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T05:06:41Z","timestamp":1660108001000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02459-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2459"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02459-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.21.480553","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"20 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Northwestern University Institutional Review Board (STU00213022). Informed consent was obtained from all subjects involved in the present study. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JL is a consultant for Eurofins\/Viracor\/Transplant Genomics and Novartis. There are no competing interest for other authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}